Adaptive Biotechnologies (ADPT) Cash from Investing Activities Growth (1y) (2019 - 2026)
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -165.43% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | -8.06% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | -289.16% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 1,052.89% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | -16.62% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | -8,716.16% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | -38.65% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | -40.88% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -1,399.37% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 51.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,399.37% |
| Mar 31, 2026 | -64.25% |
| Dec 31, 2025 | -137.31% |
| Sep 30, 2025 | 226.90% |
| Jun 30, 2025 | -43.07% |
| Mar 31, 2025 | -42.54% |
| Dec 31, 2024 | 589.71% |
| Sep 30, 2024 | -79.77% |
| Jun 30, 2024 | -84.25% |
| Mar 31, 2024 | -29.33% |
| Dec 31, 2023 | 103.29% |
| Sep 30, 2023 | -54.95% |
| Jun 30, 2023 | 686.41% |
| Mar 31, 2023 | 67.11% |
| Dec 31, 2022 | -245.13% |
| Sep 30, 2022 | 372.78% |
| Jun 30, 2022 | -88.55% |
| Mar 31, 2022 | -59.83% |
| Dec 31, 2021 | 119.77% |
| Sep 30, 2021 | 78.13% |